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Abstract
In the human fetal kidney (HFK) self-renewing stem cells residing in the metanephric mesenchyme (MM)/blastema are
induced to form all cell types of the nephron till 34
th week of gestation. Definition of useful markers is crucial for the
identification of HFK stem cells. Because wilms’ tumor, a pediatric renal cancer, initiates from retention of renal stem cells,
we hypothesized that surface antigens previously up-regulated in microarrays of both HFK and blastema-enriched stem-like
wilms’ tumor xenografts (NCAM, ACVRIIB, DLK1/PREF, GPR39, FZD7, FZD2, NTRK2) are likely to be relevant markers.
Comprehensive profiling of these putative and of additional stem cell markers (CD34, CD133, c-Kit, CD90, CD105, CD24)i n
mid-gestation HFK was performed using immunostaining and FACS in conjunction with EpCAM, an epithelial surface marker
that is absent from the MM and increases along nephron differentiation and hence can be separated into negative, dim or
bright fractions. No marker was specifically localized to the MM. Nevertheless, FZD7 and NTRK2 were preferentially localized
to the MM and emerging tubules (,10% of HFK cells) and were mostly present within the EpCAM
neg and EpCAM
dim fractions,
indicating putative stem/progenitor markers. In contrast, single markers such as CD24 and CD133 as well as double-positive
CD24
+CD133
+ cells comprise .50% of HFK cells and predominantly co-express EpCAM
bright, indicating they are mostly
markers of differentiation. Furthermore, localization of NCAM exclusively in the MM and in its nephron progenitor
derivatives but also in stroma and the expression pattern of significantly elevated renal stem/progenitor genes Six2, Wt1,
Cited1, and Sall1 in NCAM
+EpCAM
- and to a lesser extent in NCAM
+EpCAM
+ fractions confirmed regional identity of cells and
assisted us in pinpointing the presence of subpopulations that are putative MM-derived progenitor cells (NCAM
+Ep-
CAM
+FZD7
+), MM stem cells (NCAM
+EpCAM
-FZD7
+) or both (NCAM
+FZD7
+). These results and concepts provide a
framework for developing cell selection strategies for human renal cell-based therapies.
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Introduction
Identification of multipotential progenitor populations in
mammalian tissues is important both for therapeutic potential
and an understanding of developmental processes and tissue
homeostasis. Progenitor populations are ideal targets for gene
therapy, cell transplantation, and tissue engineering of bioartificial
organs(Weissman 2000; Xu et al. 2000). A demand for kidney
progenitors is increasing because of a severe shortage of donor
organs for orthotopic kidney transplantation. Because dialysis and
kidney transplantation currently are the only successful therapies
for patients suffering chronic renal failure, cell therapy with renal
progenitors offers an alternative approach for therapies of kidney
diseases(Dekel and Reisner 2006).
The early development of the mammalian metanephros, the
direct precursor tissue of the adult kidney, is a complex process
that involves highly regulated interactions between two derivatives
of the intermediate mesoderm, the wolffian duct and the
metanephric/nephrogenic mesenchyme. Reciprocal signaling
between the metanephric/nephrogenic mesenchyme and a
derivative of the nephric duct known as the ureteric bud results
in branching of the ureteric bud (UB) and condensation of
metanephric mesenchyme (MM) at its tips(Woolf 2001; Cho and
Dressler 2003). The condensed mesenchyme is thought to form a
precursor cell population, which both maintains itself at the tips of
the UB (via proliferation and/or addition from the surrounding
non-condensed mesenchyme) and gives off cells that differentiate
into nephrons, the functional filtration unit of the kidney(Rosen-
blum 2008). Recent experiments have established that the
progenitor cell in the MM fulfils the criteria of a true committed
stem cell in that is capable of self-renewing and of differentiating
towards different types of nephron epithelia(Self et al. 2006; Boyle
et al. 2008; Kobayashi et al. 2008).
The human metanephros appears at the 5
th of gestation and
renal stem/progenitor cells in the MM are induced to form
nephrons until 34 weeks of gestation(Cho and Dressler 2003;
Rosenblum 2008). For renal regeneration, both human precursor
tissue(Dekel et al. 1997; Dekel et al. 2002; Dekel et al. 2003) or
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al. 2007a) can be utilized. Isolation of specific human renal
progenitors from the MM requires the characterization of surface
markers that would enable cell collection. Given the cellular
heterogeneity in the developing human kidney(Rosenblum 2008),
eliminating the unwanted mature cell populations from further
cultivation steps, prior to transplantation, would increase the
purity of the graft and allow for a better defined cell composition
to be transferred.
While the transcriptional program specifying a renal progenitor
cell has been thoroughly contemplated(Brodbeck and Englert
2004) corresponding cell surface markers have been hardly
studied. Recently, we performed microarray studies of the human
kidney, including fetal and adult kidneys (HFK and HAK,
respectively) and their corresponding tumors, wilms’ tumor (WT)
and renal cell carcinoma (RCC) (Dekel et al. 2006b). Wilms’
tumor is classified as a primitive, multilineage malignancy of
embryonic renal precursors of the MM that are arrested in
different stages of differentiation, thus forming in the tumor a cell
population similar to condensed mesenchyme and also mature
epithelial/tubular and stromal cells(Rivera and Haber 2005).
While HFKs were heterogeneous, we used WT xenografts that by
serial passage in mice were highly enriched for blastema at the
expanse of differentiated elements(Dekel et al. 2006b; Metsuyanim
et al. 2008). We were interested in genes that were up-regulated in
both the stem-like WT xenografts and the HFK, as these were
suggested to characterize the progenitor population arising from
the MM (‘progenitor’ genes). Among these were the transcription
factors specifying the kidney progenitor cells(Kreidberg et al. 1993;
Nishinakamura 2003; Brodbeck and Englert 2004; Self et al. 2006)
including WT1, PAX2, LIM1, SIX1, EYA1, SALL1, and CITED1.I n
addition, we detected cell surface markers, including NCAM,
ACVRIIB, FZD2, FZD7, GPR39, NTRK2 and DLK1/PREF(Dekel et
al. 2006b).
The aim of the present study was to determine the protein
expression of these putative ‘cell surface progenitor markers’ in
human fetal kidneys along with universal stem cell markers of
various lineages so as to determine their relevance in character-
ization of renal stem/progenitor cells. Such characterization of
putatively therapeutic cell suspensions according to surface
markers is likely to be a prerequisite for future applications in a
clinical setting.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of Sheba Medical Center, Wolfson
hospital and Asaf Harofeh Medical Center hospitals. All patients
provided written informed consent for the collection of samples
and subsequent analysis.
Establishment of a primary culture from human kidney
HFK were collected from elective abortions. Fetal gestational
age ranged from 15 to 19 weeks. Normal HAK samples were
retrieved from borders of RCC tumors from partial nephrectomy
patients. This procedure was done following informed consent and
has been approved by the local ethical committee. Collected
tisuses were washed with cold HBSS (Invitrogen, Carlsbad, CA)
and minced into ,1 mm cubes using sterile surgical scalpels. The
dissected tissue was then incubated for 2 hours in 37uC with
Iscoves’s Mod Dulbecco’s Medium (IMDM) (Invitrogen) supple-
mented with 0.1% collagenase II (Invitrogen). The digested tissue
was then gradually forced through a 100 mm, 70 mm and 50 mm
cell strainer to achieve a single cell suspension, and after removal
of the digesting medium resuspended in growth medium [IMDM
containing 10% fetal bovine serum (Invitrogen), 100 ng/ml EGF,
100 ng/ml bFGF and 10 ng/ml SCF (R&D Systems, Inc,
Minneapolis, USA)] and plated in flasks. Cells were incubated as
described previously(Pode-Shakked et al. 2008 Nov in print) and
used for FACS analysis of progenitor marker expression and
sorting of subpopulations.. All assays were conducted with low-
passage cultured cells (passage 1 or 2).
Immunostaining of HFK
Immunostaining was performed as previously described ((da
Silva Meirelles et al. 2006)) on three different kidneys: 12, 13, 18
weeks of human gestation. Briefly, 4 mm sections of HFKs were
mounted on super frost/plus glass (Menzel, Glazer, Braunschweig,
Germany) and processed by the labeled – (strept) avidin-biotin
(LAB-SA) method using a histostain plus kit (Zymed). Heat-
induced antigen retrieval was performed by controlled microwave
treatment using an H2800 model processor (Energy Bean
Sciences, INC) in 10 mM citrate buffer, PH 6.0 for 10 min at
970C. The sections were treated with 3% H2O2 for 10 min and
stained for EZH2, CD56, CD90, DLK1, CD24, GPR39, CD133,
SIX2, FZD7, FZD2, ACRIIB and NTRK1. Table 1 summarizes
the antibodies used for immunostaining.
Negative control incubations were performed by substituting
non-immune serum for the primary antibody. Biotinylated second
antibody was applied for 10 min followed by incubation with
horseradish peroxidase –conjugated streptavidin (HRP-SA) for
10 min. Following each incubation, the slides were washed
thoroughly with Optimax wash buffer (Biogenex, San Ramon,
CA, USA). The immunoreaction was visualized by an HRP-based
chromogen/substrate system, including DAB (brown) chromogen
(liquid DAB substrate kit – Zymed). The sections were then
counterstained with Mayer’s hematoxylin, dehydrated and
mounted for microscopic examination.
Flow cytometry
FACS was performed on cultured cells originating from at least
3 independent samples ranging from 15 to 19 weeks of human
gestation. Cells were detached from culture plated with non-
enzymatic cell dissociation solution (Sigma-Aldrich Co., Ltd., St.
Louis, MO) and a viable cell number was determined using
Trypan blue staining (Invitrogen). Cells (1610
5 in each reaction)
were suspended in 50 ml of FACS buffer [0.5% BSA and 0.02%
sodium azid in PBS (Sigma-Aldrich and Invitrogen, respectively)]
and blocked with FcR Blocking Reagent (MiltenyiBiotec, Auburn,
USA) and human serum (1:1) for 15 min at 4uC. Cells were then
incubated for 45 min with a primary antibody for CD24,
NCAM1, C-KIT, Thy-1, CD90, CD34, CD133, EpCAM, PSA-
NCAM, ACVR2B, FZD7 or NTRK1 or a matching isotype
control. All antibodies used for flow cytometry labeling are
summarized in Table 2.
Cells were washed with FACS buffer, and incubated for 30 min
at 4uC with a secondary Antibody if needed [Avidin-Fluorescein,
APC Streptavidin or Alexa Fluor 647 goat anti mouse and Alexa
Fluor 488 goat anti mouse. All secondary antibodies used are
summarized in Table 3.
Cell viability was tested using 7AAD viability staining solution
(eBioscience). Cell labeling was detected using FACSCalibur (BD
Pharmingen). Flow cytometry results were analyzed using FlowJo
analysis software. Viable cells were defined by their FSC/SSC
profiles and, in addition, their lack of 7AAD. Analysis of EpCAM
subpopulations was performed by gating cell fractions according to
Stem Cell Markers in HFK
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The second marker was then examined in each subpopulation
gate. When triple staining was performed, we initially gated
EpCAM subpopulation and then examined co-staining of the
other two markers in each subpopulation.
Magnetic cell sorting
At least three independent kidney samples were used for sorting
of NCAM/EpCAM as well as PSA-NCAM subpopulations.
Sorted cells were of primary cultures established from the same
HFK used in the FACS analysis of progenitor marker expression.
Cells were detached with Trypsin/EDTA and resuspended in
growth medium. Cells were transferred trough 30 mm Pre-
Separation Filter (Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany) then washed and resuspended in pH 7.2 MACS buffer
(0.5% BSA, 2 mM EDTA in PBSX1). Cells were magnetically
labeled with NCAM1 (CD56) MultiSort MicroBeads kit (Miltenyi
Biotec GmbH) according to the manufacturer’s instructions and
positive labeled cells (NCAM
+) were enriched with LS Columns.
CD56 MicroBeads were releases from the cells with MultiSort
Release Reagent (Miltenyi Biotec GmbH) and CD56 positive cells
were further separated with EpCAM positive and negative cells
using CD326 MicroBeads (Miltenyi Biotec GmbH) on LS
Columns according to the manufacturer’s instructions. Enrich-
ment of cells to CD56 and CD326 was validated using flow
cytometry.
Quantitative reverse transcription-PCR
NCAM
+EpCAM
2, NCAM
+EpCAM
+ and NCAM
2 sub-pop-
ulations of HFK were tested for the expression of: 1. Transcription
factors specifying renal stem/progenitor cells in the MM (SIX2,
CITED1, SALL1, WT1, PAX2) (5, 6), 2. The marker pair
Vimentin/E-cadherin that are expressed in early stages of kidney
development during mesenchymal (Vim+) to epithelial (E-cad+)
conversion and differentiation (5, 6) 3. ‘Stemness’ genes (Wnt
pathway, b-catenin; Polycomb group, EZH2, BMI1) 4. Pluripo-
tency genes (NANOG, OCT4) and 5. Surface markers (ACR2B,
FZD7, NTRK2, CD133 and CD24). In addition, sorted PSA-
Table 1. Antibodies used for IHC staining.
Antibody Marker Identified Manufacturer Catalog #
Rabbit anti EZH2 EZH2 Zymed, San Francisco, CA SKU#36-6300
Monoclonal anti-human CD56 (NCAM1) CD56 Ancell Corporation, Bayport, MN, USA 208-020
Mouse anti-human CD90 CD90, thy1 AbD serotec, Kidlington, Oxford, UK MCA90
Mouse anti- Preadipocyte factor-1 DLK1, PREF1 Ray Biotec, Inc, Parkway Lane, Norcross GA NR-08-0034
Mouse monoclonal CD24 CD24 abcam, Cambridge, UK. ab31622
Six2 monoclonal antibody SIX2 ABNOVA, Walnut, USA H000010736-
M01
Rabbit polyclonal anti frizzled-7 FZD7 NOVUS biologicals, Littleton, USA NLS4900
Rabbit polyclonal anti frizzled-2 FZD2 NOVUS biologicals, Littleton, USA NLS3488
Monoclonal anti-human Activin RIIB antibody ACRIIB R&D Systems, Inc, Minneapolis, USA MAB3393
Rabbit polyclonal to GPCR GPR39 GPR39 abcam, Cambridge, UK. ab39283
Rabbit polyclonal to CD133 CD133 abcam, Cambridge, UK. ab16518
Monoclonal anti-human TrkB antibody NTRK1 R&D Systems, Inc, Minneapolis, USA MAB3971
doi:10.1371/journal.pone.0006709.t001
Table 2. Antibodies used in the flow cytometry assays.
Antibody Marker identified Isotype control Manufacturer Catalog #
CD24-PE CD24 Mouse IgG1 eBioscience San Diego, USA 12-0247
Biotin anti-human CD24 CD24 Mouse IgG1 eBioscience 13-0247
FITC anti-human CD34 CD34 Mouse IgG2a MiltenyiBiotec 130-081-001
PE anti-human CD56 (N-CAM, NCAM1) NCAM1 Mouse IgG2a,k eBioscience 12-0569
FITC mouse anti-human CD90 Thy-1 Mouse IgG1,k BD Biosciences, San Jose, USA 555595
CD133/1 (AC133)-APC CD133 Mouse IgG1 MiltenyiBiotec 130-090-826
CD326 (EpCAM)- FITC EpCAM Mouse IgG1 MiltenyiBiotec 130-080-301
Monoclonal anti-human Activin RIIB antibody ACR2B Mouse IgG1 R&D Systems, Inc. MAB3393
Biotinylated anti-human/mouse Frizzled-7 antibody FZD7 rat IgG2A R&D Systems, Inc. BAM1981
FITC mouse anti-Human CD90 CD90 Mouse IgG1,k BD Pharmingen 555595
Affinity Purified antihuman CD117 (cKit) C-KIT Mouse IgG1,k eBioscience 141179
Monoclonal anti-human TrkB antibody NTRK1 Mouse IgG1 R&D Systems, Inc. MAB3971
Anti- PSA-NCAM-PE PSA-NCAM Mouse IgM MiltenyiBiotec 130-093-274
doi:10.1371/journal.pone.0006709.t002
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+ and PSA-NCAM
2 HFK cells were analyzed for the
expression of genes included in groups 1 and 2. Total RNA from
cells was isolated using RNeasy Micro Kit (Qiagen GmbH,
Hilden, Germany) according to the manufacturer’s instructions.
cDNA was synthesized using High Capacity cDNA Reverse
Transcription kit (Applied Biosystems, California USA) on total
RNA. Real-time PCR was performed using an ABI7900HT
sequence detection system (Perkin-Elmer/Applied Biosystems) in
the presence of TaqMan Gene Expression Master Mix (Applied
Biosystems). PCR amplification was performed using gene specific
TaqMan Gene Expression Assay-Pre- Made kits (Applied
Biosystems). PCR results were analyzed using SDS RQ Manager
1.2 software. Statistical analysis was performed using a non-paired
2-tails T-test. Statistical significance was considered at P,0.05.
Results
Characterization of putative stem/progenitor markers in
the HFK
SIX2. Of the multiple regulatory genes specifying renal
progenitors, SIX2 is a transcription factor that has been shown
in mice to specify self-renewing epithelial renal stem cells that have
the ability to give rise to all cell types in the nephron(Rosenblum
2008). Immunostaining of mid-gestation HFK revealed
localization of such SIX2-expressing cells to the MM, specifically
to the cap mesenchyme (CM), where renal stem cells are suggested
to reside(Boyle et al. 2008; Rosenblum 2008) (Fig. 1a–b). While
unsuitable for human cell sorting, SIX2 staining highlights the
location of the desired putative MM stem cells.
EpCAM (CD326). The Epithelial Cell Adhesion Molecule
(EpCAM) is expressed virtually on all normal epithelia in
vertebrates(Trzpis et al. 2008) and can therefore serve as a
marker for epithelial differentiation. Accordingly, Trzpis et
al(Trzpis et al. 2007) have recently shown that in mid-gestation
HFK (by 10 weeks of gestation), hEpCAM was expressed by the
ureteric bud (UB) and comma-shaped (C) and S-shaped (S) bodies,
whereas the MM did not express hEpCAM. Moreover, they found
differential hEpCAM staining levels during nephrogenesis, where
the weakest staining for hEpCAM was observed in the C- and S-
shaped bodies, which are progenitor nephron derivatives of the
MM and higher levels in the UB and developing tubules of the
nephron, indicating a correlation between hEpCAM levels and the
degree of epithelial differentiation. We examined cell populations
of low-passage HFK cells by flow cytometry and revealed that
80.0611.2% of the cells express EpCAM (Fig. 2a–b). This result
correlated with its wide spread distribution in epithelial cells of the
developing kidney. Moreover we detected two subpopulations
within the EpCAM
+ population, EpCAM
dim and EpCAM
bright,
suggestive of epithelial progenitor and more differentiated tubular
cells, respectively (Fig. 3a). A clearer separation between
Table 3. Secondary Abs or S/A conjugated enzymes used in
flow cytometry assays.
Reagent Manufacture company #
Avidin-Fluorescein (Avidin-FITC) R&D Systems, Inc. F0030
APC Streptavidin BD Biosciences. 554067
Alexa Fluor 647 goat anti mouse Invitrogen A31625
Alexa Fluor 488 goat anti mouse Invitrogen A31620
doi:10.1371/journal.pone.0006709.t003
Figure 1. Immunostaining of putative stem cell markers. (a–j)
Representative immunostaining of SIX2, NCAM1, FZD7, ACVR2B and
NTRK2 in paraffin embedded sections of HFK (12, 13 and 18 weeks of
human gestation); (a–b) localization of SIX2 to the MM, predominantly
to the CM. (c–d) predominant staining of NCAM1 in the MM (including
CM) and its derivatives (S- and comma- shaped bodies) and renal
stroma, but not mature tubules or UBs. (e–f) FZD7 demonstrates
preferential localization to the nephrogenic zone including MM and its
derivatives, UBs, and newly forming tubules but not the stroma. (g–h)
ACVRIIB immunostaining demonstrates predominant expression in the
nephrogenic cortex; MM and its derivatives (S and comma shaped
bodies), UBs, parietal epithelium of fetal glomeruli but not in the
stroma. (i–j) NTRK2 is detected in the MM (including condensates) and
its derivatives, UBs and some differentiated tubules. Figures c, e and g
are shown in low magnification (original64), Figures a, b, d, f and h–j
are shown in higher magnifications (original640; I, original620).
doi:10.1371/journal.pone.0006709.g001
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PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6709Figure 2. FACS analysis of single putative stem cell surface markers in HFK cells. (a) Representative flow-cytometry histograms of surface
marker molecules (green) EpCAM, NCAM1, FZD7, NTRK2, CD90, CD34, CD24, CD133, and their respective isotype controls (red) in HFK (19 weeks of
gestation). (b) Summarizing bar graph of single marker staining in HFK (15–19 weeks of gestation). Each marker was tested on at least 3 independent
samples. Data were calculated as average % of expressing cell6SD. Each marker was tested in 10 HFK.
doi:10.1371/journal.pone.0006709.g002
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PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6709Figure 3. FACS analysis of putative stem cell markers in EpCAM subpopulations. (a) Representative zebra graph of EpCAM staining and
the subpopulation gating. EpCAM subpopulations were gated according to EpCAM staining intensity (negative, dim or bright) versus FSC. (b)
Representative dot plot graphs of NCAM1, PSA-NCAM, FZD7, NTRK2, CD24 and CD133 expression levels in EpCAM subpopulations of HFK. Quadrates
were placed according to isotype control confiding the negative staining to the lower left quadrant. Percentage of cells in each subgroup appears on
the lower right quadrant. (c) Summarizing bar graphs of NCAM1, PSA- NCAM, NTRK2, FZD7, CD24 and CD133 expression levels in EpCAM
subpopulations. Data are average % of cells in each subgroup6SD. Analysis of each marker was performed at least three times.
doi:10.1371/journal.pone.0006709.g003
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dim and EpCAM
bright cell populations was noted in older
HFK.
NCAM1 (CD56). Transcript levels were up-regulated in both
HFK and stem-like WT xenografts (.three-fold increment) (Dekel
et al. 2006b). Immunostaining of sections of HFK (14–20 week)
demonstrated predominant staining in the nephrogenic zone and
renal stroma, while mature tubules were devoid of staining. In the
nephrogenic zone, we observed strong expression in the CM,
similar to SIX2 and also in early S and C shaped nephron figures
(i.e., MM and its derivatives) and newly forming tubules but not in
UBs (Fig. 1c–d). This staining pattern of NCAM has been observed
in the developing mouse kidney(Klein et al. 1988; Bard et al. 2001).
Examination of populations HFK cells by single staining flow
cytometry revealed that 29.168.2% of the cells express NCAM
(Fig. 2a–b), representing nephrogenic zone and stroma-derived
NCAM expressing cells.Wefurtherdetected two sub-populations of
NCAM
+ cells, NCAM
+EpCAM
2 (13.564.9% of total cells) and
NCAM
+EpCAM
+ (14.563.7% of total cells). Because EpCAM is
not expressed in the stroma or in the MM, the NCAM
+EpCAM
2
subpopulation is indicative of cells originating from both of these
areas, while NCAM
+EpCAM
+ cells are a heterogeneous pool of
progenitor cells from the nephrogenic zone, including newly
developed tubules. This sub-population could be further separated
into NCAM
+EpCAM
dim and NCAM
+EpCAM
bright cell fractions
(Fig. 3). In the EpCAM
dim population a significantly larger fraction
consists of NCAM expressing cells compared to that found in the
EpCAM
bright cell fraction (P,0.0001) (Fig. 3b), further indicating
NCAMasanepithelial progenitormarker.Takingintoaccount that
in the nephrogenic zone low levels of EpCAM were previously
noted in the immediate MM-derived structures (S- and C-shaped)
and higher levels in emerging tubules, the NCAM
+EpCAM
dim cells
possibly represent the former. In addition, we have analyzed the
long chain form of polysialic acid (PSA) characteristic of the low
adhesive embryonic form of NCAM (PSA-NCAM), representing a
post-translational modification and therefore relevant at the protein
level. This surface marker closely resembles NCAM’s staining
pattern (various developmental stages including condensed MM,
renal vesicles, the distal portion of S-shaped bodies, and primitive
tubules) but is not detected in the renal stroma(Roth et al. 1988).
Accordingly,wefoundPSA-NCAMtobeexpressedin8.663.2%of
HFK cells (2a–b) and to peak in the EpCAM
dim cell fraction
(P,0.015 compared to the EpCAM
bright cell fraction) (Fig. 3b).
Furthermore, PSA
+EpCAM
2 and PSA
+EpCAM
+ cell fractions are
more limited in expression by comparison to NCAM/EpCAM
(2.361.3% and 4.260.9% of total cells, respectively). Interestingly,
when applying triple staining for PSA-NCAM, NCAM and
EpCAM we found the putative MM cell fraction, NCAM
+PSA-
NCAM
+EpCAM
2,to be expressedin2.562.2%oftotal cells,while
NCAM
+PSA-NCAM
+EpCAM
+ from later developmental stages in
4.360.3% of total cells (Fig. 4), indicating that PSA-NCAM and
NCAM localize in similar progenitor areas. We could not detect
NCAM
2PSA-NCAM
+EpCAM
2 cells.
Frizzled 2,7 (FZD2, FZD7). Both transcript levels of FZD2 and
FZD7 (Wnt receptors) were up-regulated in both HFK and stem-like
WT xenografts(Dekel et al. 2006b). Recently, activation of the Wnt/b-
catenin pathway has been shown to maintain the progenitor pool in the
MM(Schmidt-Ott and Barasch 2008). Thus, FZD proteins represent
surface marker molecules that may have a functional role in
maintaining progenitor cells. Immunostaining HFK revealed that
while FZD2 demonstrated widespreade x p r e s s i o n( F i g .5 a – b ) ,s t a i n i n g
all of the tubular cells, FZD7 was detected predominantly in the
nephrogenic zone, staining all cell types in that area [MM (both loose
and condensed mesenchyme), UBs, early nephron figures, newly
forming tubules] but not at all in renal stroma (Fig. 1e–f). Correlating
with its reserved localization, FZD7 was detected in only 9.563.7% of
the HFK cells (Fig. 2a–b). Examination of the FZD7 expressing cells in
relation with EpCAM sub-populations, showed that largest fractions of
FZD7
+ cells exists within the EpCAM
neg and EpCAM
dim fraction and
to a much lesser extent in the EpCAM
bright cell fraction (P,0.02)
(Fig. 3b). Thus, while EpCAM
+FZD7
2 cells represent the largest
fraction (53.8613.4% of total cells), we observed FZD7
+EpCAM
+cells
(3.961.2% of total cells) which likely represent MM- and UB- derived
progenitors and FZD7
+EpCAM
2cells (2.560.6% of total cells), which
may originate solely from the MM. Furthermore, using triple FACS
staining of HFK cells that also includes NCAM (Fig. 4b) we were able
to demonstrate cell populations of the FZD7
+EpCAM
+NCAM
+
progenitor phenotype (MM-derived, 2.561.0% of total cells,
4.761.0% FZD7
+NCAM
+ cells within the EpCAM
+ population) as
well as FZD7
+NCAM
+EpCAM
2 (0.660.5% of total cells, 2.260.7%
FZD7
+NCAM
+ cells within the EpCAM
2 population) and
surprisingly also FZD7
+EpCAM
2NCAM
2 phenotypes (2.060.8%
of total cells, 7.864.18% FZD7
+NCAM
2 cells within the EpCAM
2
population), which are both likely to represent putative MM-
originating stem cells.
Activin receptor IIB (ACVRIIB). ACVRIIB qualified as a
microarray predicted marker. Interestingly, mice lacking
ACVRIIB show abnormalities in kidney development and in
anterior/posterior patterning of the axial skeleton show
abnormalities(Oh and Li 1997; Esquela and Lee 2003), further
emphasizing functional importance in the renal progenitor
population. Similar to NCAM and FZD7, in the sections of
HFK, ACVRIIB was preferentially localized to the nephrogenic
zone, showing strong expression in all structure types (blastema,
UBs, C- and S-shaped bodies and also developing tubules).
ACVRIIB was also detected in parietal epithelium of fetal
glomeruli but not on stromal cells (Fig. 1g–h). A similar staining
pattern was observed by in-situ hybridization of E14.5 mouse
kidneys (robust expression of ActRIIB mRNA in the condensed
MM, differentiating nephrons and UB branches). While according
to its localization ACVRIIB has potential as a renal progenitor
marker, FACS analysis of HFK cells showed extremely varying
expression levels and precluded its further investigation.
NTRK2. NTRK2 qualified as a microarray predicted marker
as similar to FZD7 it was up-regulated in microarrays of WT-stem
like tumors and HFK. Previous analysis of the developing mouse
kidney showed NTRK2 to localize to the MM while in WT
NTRK2 has been suggested as a bad prognostic marker(Durbeej et
al. 1993). Immunostaining of the HFK showed NTRK2 to localize
to cells within the MM but also to early differentiation stages in the
nephrogenic zone and some differentiated tubules but not stroma
(Fig. 1i–j). FACS analysis revealed NTRK2 to stain 12.163.4% of
the HFK (Fig. 2a–b). Analysis of NTRK2 according to EpCAM
subpopulations revealed a tendency towards higher expression
levels in both the negative and dim fraction compared to the bright
one (Fig. 3b). To further strengthen the presence of progenitor
phenotypes we found by triple staining of NTRK2 along with
NCAM and EpCAM, EpCAM
+NCAM
+NTRK2
+ cells (3.162.5%
of total, 6.863.3% NCAM
+NTRK2
+ cells within the EpCAM
+
population) as well as putative MM stem cell populations,
EpCAM
2NCAM
+NTRK2
+ cells (0.6160.3% of total, 3.362.5%
NCAM
+NTRK2
+ cells within the EpCAM
2 population) and
EpCAM
2NCAM
2NTRK2
+ cells (2.762.4% of total, 7.562.7%
NCAM
2NTRK2
+ cells within the EpCAM
2 population) (Fig. 4b).
GPR39, DLK1. These markers, up-regulated in microarrays
of both HFK and stem-like WT xenografts, were found to be
ubiquitously expressed in differentiated renal tubular epithelial
cells in sections of HFK while only faintly positive or negative in
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PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6709Figure 4. FACS analysis of putative stem cell markers in NCAM/EpCAM subpopulations. (a) Representative dot plot graphs of EpCAM
staining. Cells were gated in two groups: EpCAM negative (neg) and EpCAM positive (pos) versus FSC. (b) Representative dot plot graphs of PSA-
NCAM, FZD7, NTRK2, CD24 and CD133 co-staining with NCAM in EpCAM positive or negative populations of mid-gestation HFK. Quadrates were
placed according to the isotype control confiding the negative staining to the lower left quadrant. Percentage of cells for each quadrant appears in
the quadrant. (c) Representative dot plot graphs of CD24 and CD133 co-staining in EpCAM subpopulations of HFK. Quadrates were placed according
to the isotype control confiding the negative staining to the lower left quadrant. Percentage of cells for each marker combination appears in the
quadrant. (d) Summarizing bar graphs of CD24 and CD133 co-staining in EpCAM Subpopulations. Data are average % of cells in each subgroup6SD.
Analysis of each marker was performed at least three times.
doi:10.1371/journal.pone.0006709.g004
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eliminated from FACS analysis (Fig. 5c–d and e–f, respectively).
CD34. CD34 is a well known marker of hematopoietic stem
cells (HSC) (Dekel et al. 2006a). FACS analysis demonstrated
CD34 to be expressed in 14.4612.9% of HFK cells (Fig. 2a–b).
Immunostaining for the CD34 protein specifically demonstrated
widespread endothelial localization (glomerular and peri-tubular)
in all parts of the HFK (Fig. 5g–h), including in the nephrogenic
zone whereas CM and other epithelial progenitor structures are
devoid of CD34 expression. CD34 is therefore not an epithelial
stem cell marker in the HFK but rather a marker for vascular
differentiation. c-Kit, an additional hematopoietic stem cell
marker, was not detected in the HFK cells.
CD90. Antigenic phenotypes of adult MSC consistently
include CD90 and CD105(Dominici et al. 2006). In addition,
CD90 was shown to be broadly expressed on heterogeneous rat
FK cells transplanted to injured kidneys(Kim et al. 2007b).
Immunolocalization of CD90 in the HFK revealed predominant
expression in renal tubular cells but not in the nephrogenic zone
(Fig. 5i–j) and 25.368.5% of HFK cells expressed CD90.
CD24. CD24 was not differentially expressed in the
developing human kidneys or in WT stem-like xenografts.
Nevertheless, the previous demonstration of CD24 as
characteristic of the molecular phenotype of renal progenitor
cells in the developing mouse kidneys(Challen et al. 2004), as well
as the utilization of CD24 (along with CD133) to specify human
renal progenitor cells(Lazzeri et al. 2007) from developing human
kidneys, have led us to examine its expression. Immunostaining of
HFK showed widespread expression and localized CD24 to
mature tubules (renal stroma was devoid of CD24) (Fig. 5k–l).
Accordingly, FACS analysis demonstrated that approximately
73.6620.6% of HFK cells express CD24 (Fig. 2a–b). When
analyzed in regard with EpCAM sub-populations, the abundance
of CD24 expressing cells increases along epithelial differentiation
(in contrast with for instance FZD7) so that approximately 80% of
the EpCAM
bright cells are CD24
+ cells (P,0.0001 compared to
CD24
+ cells found in the dim and negative fractions) (Fig. 3b),
indicating that CD24 is predominantly a marker of differentiation
in the HFK. Moreover, triple staining with NCAM revealed that
CD24 is expressed in low levels only in putative MM fractions;
CD24
+NCAM
+EpCAM
2 and CD24
+NCAM
2EpCAM
2 cell
fractions (2.061.2%, 3.762.8% of total cells, respectively) in
contrast to a CD24
+NCAM
2EpCAM
+ differentiated phenotype
(34.1614.6% of total cells) (Fig. 4b). Thus, sorting cells from the
HFK according to CD24 would result in a heterogeneous
population comprised predominantly of differentiated cells and
to a much lesser extent of stem/progenitor cells.
CD133. Although the biological function of CD133 remains
unknown, CD133 is recognized as a stem cell marker for normal
and cancerous tissues(Shmelkov et al. 2008). Indeed, CD133 alone
or in a combination with other markers is currently used for the
isolation of stem cells from numerous tissues, such as bone
marrow, brain, prostate, liver, pancreas(Uchida et al. 2000; Salven
et al. 2003; Sugiyama et al. 2007; Shmelkov et al. 2008), and both
developing and adult kidney (along with CD24)(Sagrinati et al.
2006; Lazzeri et al. 2007). Among adult organs, the kidney has
been reported to have large numbers of CD133
+ cells
35,
(Weigmann et al. 1997). As previously shown for the fetal
pancreas, we could not detect CD133 positivity in HFK tissue.
However, FACS analysis of HFK cells demonstrated that
56.9615.8% of the cells express CD133 (Fig. 2a–b).
Furthermore, the EpCAM
bright fraction contained the largest
population of CD133 expressing cells with significantly smaller
populations in EpCAM
dim and EpCAM
neg cells (P,0.0001)
Figure 5. Immunostaining of putative stem cells markers. (a–l)
Representative immunostaining of FZD2, GPR39, DLK1, CD34, CD90 and
CD24 in paraffin embedded sections of HFK (12, 13 or 18 weeks of
gestation); (a–b) FZD2 immunostaining demonstrates widespread
staining of renal tubules. (c–d) GPR39 immunostaining demonstrates
ubiquitous expression in differentiated renal tubular and to a lesser
extent in componenets of the nephrogenic cortex. (e–f) Dlk1
immunostaining demonstrates ubiquitous expression in differentiated
renal tubular but not in MM and its derivatives renal, UBs or stroma. (g–
h) CD34 immunostaining demonstrates exclusive localization to
endothelial cells (glomerular and peri-tubular) in all parts of the HFK,
including in the nephrogenic cortex. (i–j) CD90 immunostaining
demonstrates predominant staining in renal tubular cells but not in
MM and its derivatives, UBs or stroma. (k–l) CD24 immunostaining
demonstrates widespread expression in mature tubules. Figure (c) is
shown in low magnification (original64), Figures a, e, g, i, k and b, d, f,
h, j, l are shown in higher magnifications (original620 and640,
respectively).
doi:10.1371/journal.pone.0006709.g005
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demonstrated a large population of CD133
+EpCAM
+NCAM
2
cells (29.5610.6% of total cells) and a relatively small ones of the
CD133
+NCAM
+EpCAM
+ (14.464.5% of total cells) and
CD133
+NCAM
+EpCAM
2 putative progenitor and stem
phenotypes (1.161.2% of total cells) (Fig. 4b). Because
CD24
+CD133
+ cells have been recently suggested a renal ‘stem
cell’ fraction(Lazzeri et al. 2007), we analyzed expression of
CD133 in conjunction with CD24. Double staining showed that
the CD24
+CD133
+ fraction comprises 55.566.4% of the HFK
cells, while triple staining with EpCAM showed that within the
EpCAM
bright fraction approximately 60% of the cells are
CD24
+CD133
+ and to a much lesser extent in the EpCAM
dim
and EpCAM
neg cell fractions (P,0.0001) (Fig. 4c). Thus, similar to
cells expressing the CD24 marker, most of the CD133
+ cells in the
HFK and also CD133
+CD24
+ cells are of a differentiated tubular
phenotype and are not likely to be exclusive to the stem/
progenitor pool.
HFK cell sub-populations retain molecular aspects of
regional identity. Because immunostaining of HFK
demonstrated that markers are regionally specified we wanted to
verify that regional differences are maintained in HFK cells in
addition to FACS separation according to EpCAM intensity levels.
A sap r o o f - o f - p r i n c i p l ew ec h o s et oa n a l y z es o r t e d
NCAM
+EpCAM
2,N C A M
+EpCAM
+ (containing putative MM
stem- and MM-derived progenitor cells, respectively) in comparison
with NCAM
2 HFK cell populations as NCAM and EpCAM are
important surface markers for our characterization system. Although
a heterogeneous cell population (see before), NCAM
+EpCAM
2 cells
highly overexpressed (.five fold) most MM stem/progenitor genes in
five separate HFK (Fig. 6a), levels of which were already reduced in
the NCAM
+EpCAM
+ cell fraction (presumably more differentiated),
but still higher (Wt1, Sall1)i nc o m p a r i s o nw i t ht h eN C A M
2 cell
fraction (Fig. 6a), indicating a hierarchy for enrichment for the renal
‘progenitor’genes.ConsiderablylowerE-cad levelswere observedfor
the NCAM
+EpCAM
2 and NCAM
+EpCAM
+ cell fractions, while
NCAM
+EpCAM
2alsosignificantly overexpressed vimentin(Fig.6b).
In addition, while there was a tendency for elevation of the ‘stemness
genes’ in the NCAM
+ fractions, only b-catenin achieved significance
in NCAM
+EpCAM
2cells(Fig.6c),mostlikelyduetolargevariations
across human samples. Finally, analysis of surface marker expression
in the sorted sub-populations showed elevated FZD7, ACVRIIB and
NTRK2 in the NCAM
+ fractions (both FZD7 and NTRK2 genes
significantly overexpressed in the NCAM
+EpCAM
2 fractions) as
opposed to CD24 and especially CD133 (Fig. 6d). Similar results
were found when analyzing expression in sorted PSA-NCAM
+ cells
by comparison to the negative fraction. PSA-NCAM (see before)
showed significant enrichment for Six2, Sall1, Wt1 and Pax2 (Fig. 7a)
as well as reduced levels of E-cadherin (Fig. 7b), all indicative of a
stem/progenitor origin. Thus, HFK cells retain aspects of regional
identity as determined by marker immunostaining.
Marker expression in the human adult kidney
(HAK). Renal cell progenitor markers are expected to decrease
once maturation occurs. We therefore analyzed cell surface
marker expression in the HAK. Indeed, flow cytometry analysis
of HAK cells for single marker expression revealed reduced PSA-
NCAM, FZD7, NTRK2 and NCAM levels compared to HFK,
indicative of a progenitor origin (Fig. 8a). In contrast, similar and
even increased expression levels in the HAK were observed for
CD105, CD90, CD133 and CD24 (Fig. 8a). Moreover,
CD24
+CD133
+ cells represent a large cell fraction in the HAK,
comprising 64.26610.15% of the total cells (Fig. 8b), precluding
these markers from exclusively specifying a progenitor pool.
Discussion
In the present study, we have analyzed for the expression of
putative stem cell markers in the in the human fetal kidney. Using
comprehensive immunocytochemical and flow cytometric analysis
of HFK cells, we characterized the expression profile of a variety
of surface antigens some of which are considered markers of
organ-specific stem cells and the others have been recently
suggested by us to appear on malignant renal stem/progenitor
cells of wilms’ tumors and in the developing human kidney(Dekel
et al. 2006b). Given the similarities in molecular marker expression
in progenitors from wilms’ tumors and the developing human
kidney, it appears likely that these cell populations are derivatives
of the same lineage. Our data suggest that none of these putative
stem cell markers are restricted to kidney-specific epithelial stem/
progenitor cells, but on the contrary, stem cell markers are always
also expressed on differentiated elements. The necessity for marker
combination is shown not only by lack of specific staining of the
nephrogenic mesenchyme but also by high percentage of
expression of single markers in HFK cells, over 50% of cells for
markers such as CD24 and CD133, as well as the relative high
marker abundance within the EpCAM
bright fraction and persis-
tence in high levels in the HAK. Because CD24 and CD133
mostly qualify as markers for identification of differentiated
tubular cells, their combination will not enrich for a progenitor
phenotype. Thus, areas previously reported to contain renal stem
cells in the adult kidney [35] might not necessarily originate from
stem cells but rather contain differentiated cells with clonogenic
proliferating capacities as recently shown for pigmented ciliary
epithelial cells (Cicero et al. 2009).
More relevant for the enrichment of stem/progenitor cells is the
utilization in combination of at least one of the markers that were
found to localize predominantly to the nephrogenic zone and to a
muchlesserextent to differentiated epithelia (NCAM,PSA-NCAM,
FZD7, and NTRK2). Moreover, these markers are less abundant in
HFK cells and decline in the adult kidney. The maintenance of
regional identity of HFK cells was exemplified by these markers’
abundance in EpCAM
neg and EpCAM
dim fractions as well as by
analyzing sorted NCAM expressing cell subpopulations (including
its embryonic form, PSA-NCAM) and showing mostly highly
significant differences in genes that are well-established early
markers of kidney stem/progenitor cells (Six2, Wt1, Pax2, Cited1,
and Sall1). Interestingly, we have recently identified NCAM as a
candidate marker for the renal malignant progenitor population of
wilms’ tumor(Pode-Shakked et al. 2008 Nov in print). Because
NCAM is not at all expressed on UBs or differentiated epithelia it
can be extremely useful for positive selection of MM-derived
progenitor nephron populations (NCAM
+X
+) if the second marker
is clearly not detected on MM and stromal cells. This definition is
most suitable for the NCAM
+EpCAM
+ fraction we detected among
the HFK cells and shown to enrich, at least in part, for the renal
‘progenitor’ genes. Moreover, because EpCAM is differentially
expressed in the nephrogenic zone(Trzpis et al. 2007), identification
of the NCAM
+EpCAM
dim subset, possibly pinpoints an earlier
MM-derived progenitor population (Fig. 9). Second markers that
are expressed in all parts of the nephrogenic zone and are not
detected on stromal cells potentially produce populations that
include both MM-stem cells and a heterogeneous MM-derived
progenitor population of the nephrogenic zone. This includes a
wide variety of second marker combination, such as the rather small
and discrete populations of NCAM
+FZD7
+ or NCAM
+NTRK2
+
cells we identified, but potentially also larger NCAM
+CD24
+ and
NCAM
+CD133
+ cell populations (if indeed CD133 will be directly
shown not to localize to stromal cells).
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is demonstrated by triple FACS staining of these cell populations
with EpCAM and analysis for those populations that totally lack
epithelial differentiation (EpCAM
neg). In all cases these were the
smallest populations by comparison to EpCAM expressing
fraction, showing NCAM
+FZD7
+EpCAM
2, NCAM
+NTR-
K2
+EpCAM
2 and NCAM
+CD133
+EpCAM
2 cell fractions to
be #1% of HFK cells, and NCAM
+PSA-NCAM
+EpCAM
2
,2.5% of the cells. Interestingly, within the EpCAM
neg fraction
there were NCAM
2FZD7
+ or NCAM
2NTRK2
+ but not
NCAM
2PSA-NCAM
+ cells. These findings correlate with staining
patterns in which FZD7 and NTRK2 also localize to loose
mesenchyme (LM) while PSA-NCAM appears with condensation,
possibly indicating the former fractions to arise from LM (Fig. 9).
Figure 6. Gene expression analysis in sorted NCAM/EpCAM subpopulations. Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR) analysis of (a) renal stem/progenitor genes (Six2, Cited1, Sall1, Wt1 and Pax2), (b) vimentin and E-cadherin (c) ‘stemness’ genes (b-catenin/
CTNNB1, EZH2, BMI1, Nanog and Oct4) and (d) surface marker (FZD7, ACR2B, NTRK2, CD24 and CD133) gene expression in NCAM/EpCAM magnetically
separated cells from HFK (15–19 weeks of gestation). Normalization was performed against control HPRT expression and RQ calculated relative to the
NCAM- fraction. Data were calculated as average6SD of at least 3 independent samples. ***P,0.001, *P,0.05 versus NCAM-. Sall1 expression in
NCAM
+ EpCAM
+ cells was near significance (p,0.059).
doi:10.1371/journal.pone.0006709.g006
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PLoS ONE | www.plosone.org 11 August 2009 | Volume 4 | Issue 8 | e6709Figure 7. Gene expression analysis in sorted PSA-NCAM subpopulations. Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR) analysis of (a) renal stem/progenitor genes (Six2, Cited1, Sall1, Wt1 and Pax2), (b) vimentin and E-cadherin genes expression in PSA-NCAM
magnetically separated cells from HFK (15–19 weeks of gestation). Normalization was performed against control HPRT expression and RQ calculated
relative to the PSA-NCAM
2 fraction. Data were calculated as average6SD of at least 3 independent samples. ***P,0.001, *P,0.05 versus PSA-
NCAM
2. Sall1 expression in NCAM
+ EpCAM
+ cells was near significance (p,0.059).
doi:10.1371/journal.pone.0006709.g007
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one negative is likely to be cumbersome and therefore eliminating
EpCAM after positively selecting for a single marker that is
expressed exclusively along the developmental stages of renal
epithelia (MM, MM/UB-derived progenitors, developing and
developed tubules but not stroma) might be more practical for
sorting MM-enriched stem cells. In this setting, using an initial
marker that localizes preferentially to the nephrogenic zone as
opposed to a predominantly marker of differentiation is advanta-
geous. One such potential combination includes the very small but
consistent population of FZD7
+EpCAM
2 or PSA-NCAM
+Ep-
CAM
2 cells. In any event, the relative paucity of stem/progenitor
phenotypes highlights the need for early sorting of HFK cells
according to marker molecules followed by their expansion in vitro
rater than application of multipassage culture of unsorted
heterogeneous HFK cells for cell selection (Loo et al. 2008).
The profiling of renal surface antigens initiated here forms the
basis for exploring other markers and for investigating the function
of suggested progenitor cell sub-populations in the renal context
(Fig. 9). Clearly, this profiling of surface marker antigens needs to be
extended so that a more complete picture of progenitor renal cell-
cell interaction can be achieved. Moreover, new markers for renal
stem/progenitor cells will be probably identified in the future and
that the results obtained in this study will potentially need to be
updated. Nevertheless, already at this stage, this study may prove
particularly useful for potential application of cell-based therapies of
renal diseases as well as for diagnosis of renal tumor stem cell
populations, where the same markers may have similar relevance.
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